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tablet regimen and avoidance of an increased heart attack risk. Not being tied to 
mealtime dosing was a lower priority.
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Objectives: Antibiotics have played a magic role in controlling infectious diseases 
in humans. However their indiscriminate use and prescriptions have rendered over-
whelming level of pathogenic bacteria resistant, which has resulted in increased 
mortality, morbidity and increased rates of hospitalizations incurring significant 
economic losses. Self-medication and misprescription of antibiotics at pharmacy 
stores are one of the major contributory factors in speeding up this phenomenon of 
resistance in bacterial communities. The aim of this study was to survey and assess 
the unregulated and indiscriminate sale of antibiotics in pharmacy stores in Khyber-
Pakhtunkhwa province in Pakistan. MethOds: In this study several pharmacy stores 
in two major cities, Mardan and Swabi, in Khyber-Pakhtunkhwa province in Pakistan 
were checked on two criteria; whether there were qualified and certified pharmacists 
available, and whether they demanded any doctor/ hospital prescription while giv-
ing antibiotics. Results: About 80 percent of the people sitting on the counter in 
pharmacies were not certified pharmacists, and 100 percent did not bother to demand 
any doctor’s prescription while selling antibiotics. cOnclusiOns: This is an indica-
tion of an inevitable disaster to the healthcare system, which can potentially lead 
to enormous losses to human lives and economy. An urgent need of legislation on 
antibiotics therapy in Pakistan is the need of the day; otherwise we will be left with 
no choice than to surrender to deadly microbial diseases.
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Objectives: A high level of vaccine acceptance is an important requirement for suc-
cessful vaccination programmes. Therefore, vaccine acceptance is a common criteria 
considered in national immunisation decision-making processes. This systematic 
review aimed to assess the acceptance of herpes zoster (HZ) vaccination among 
the target group (i.e. people aged 50 years and older) and physicians. MethOds: A 
PubMed search was performed for identifying English and German language publica-
tions on studies assessing HZ vaccine acceptance published before June 2015. A study 
was included if it provided information on awareness, knowledge, attitudes and/or 
perceived barriers regarding HZ vaccination among people aged 50 years and older 
or physicians. Results: After the study selection process, 15 studies remained to be 
included in the review. Ten of these studies investigated aspects of vaccine acceptance 
in the target group. Five studies concentrated on the perspective of physicians. Almost 
all studies used quantitative research methods; one study used a qualitative design 
based on focus group interviews. Most of the interviewed patients and physicians 
attached great importance to the HZ vaccine. However, when compared to influenza 
and pneumococcal vaccination, HZ vaccination was considered as a less important 
clinical priority by physicians. From the perspective of the target group, the primary 
care physician’s recommendation was a crucial factor in reaching a high level of vac-
cine acceptance. The main barriers of vaccine acceptance were the price of the vac-
cine, concerns about side effects and the perception of low risk of HZ. cOnclusiOns: 
This review identified several factors influencing the acceptance of HZ vaccination. 
Successful implementation of HZ vaccination might depend on the health care pro-
vider’s attitude, the reimbursement of costs and the target group’s knowledge on HZ.
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Objectives: To describe patterns and factors influencing real-world management 
of Danish patients infected with Hepatitis C virus (HCV). MethOds: From DANHEP, 
a national Danish HCV/HBV registry, we identified HCV genotype 1 or 4 patients 
initiating the following treatment strategies between 2011 and 2014 (excluding 
early access programs): 2nd and 1st generation direct-acting antivirals (2GDAA 
and 1GDAA), dual therapy (DT), or no treatment (NT). Patients could have ≥ 1 treat-
ment episode. We estimated proportion treated, treatment duration, and describe 
patients according to HCV strategy initiated. Results: Among 1,988 patients with 
7,209 treatment episodes (including NT), proportion of patients treated yearly was 
low (range: 0.9-4.2%) and lowest in 2013, just prior to 2GDAA market entry. In 2014, 
96.4% (53/55) of treatment episodes (excluding NT) were with 2GDAAs. Most 2GDAA 
treatments initiated were interferon-free (N= 44/53; 83.0%), with uptake highest 
for simeprevir-sofosbuvir (31/53; 58.5%) and sofosbuvir-daclatasvir (11/53; 20.8%) 
combination therapy. Average completed treatment duration (in weeks) with 
2GDAAs (13.8, SD= 5.4; N= 33) was shorter than for 1GDAAs (32.0, SD= 17.7; N= 102) 
and DT (32.2, SD= 17.9; N= 42), in accordance with approved treatment duration. 
Interferon-free 2GDAA treatment with ribavirin (16.6, SD= 4.7; N= 12) was longer 
than without ribavirin (12.0, SD= 4.4; N= 13); ribavirin may selectively be used for 
harder to treat patients as suggested by higher cirrhosis prevalence (76.9% vs. 56.5%) 
and previous treatment exposure (64.7% vs. 44.4%). Patients initiating 2GDAAs 
were more commonly cirrhotic (55.6% vs. 30.8% for 1GDAA, 35.3% for DT, 15.5% for 
NT) and previously treated (50.9% vs. 35.3% for 1GDAA, 26.2% for DT, 3.7% for NT) 
than initiators of other strategies, in line with Danish reimbursement criteria for 
2GDAAs. cOnclusiOns: Proportion of patients treated remains low (< 5%), despite 
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Objectives: Existing tools for sexual function are mostly focused to the erectile 
dysfunction and do not measure the domains important for patients living with 
HIV/AIDS (PLVHA) or HCV (PLVHC) such as stigma, fear of transmission, or type 
of sexual practices. MethOds: An exploratory descriptive qualitative phenom-
enological study was conducted in France based on face to face interviews with 
PLVHA and/or PLVHC. Sample was selected to represent different medical, social 
and demographic situations. The open coding of the interviews allowed validat-
ing a book of 433 codes. They were organized into dimensions of the conceptual 
framework. Results: 28 interviews were conducted: 17 PLVHA, 8 PLVHC and 3 
co-infected. The median age was 48.5 years [29; 74] with 11 women, 6 men and 
1 transsexual. The transmission modes were homosexual (11), heterosexual (10), 
intravenous drug use (5) and blood transfusion (2). Majority of PLVHA (88.2 %) 
and all co-infected were under HIV treatment. The thematic coding revealed the 
following dimensions: HIV impact, sexuality (sexual life, practice, satisfaction 
and difficulties), prevention and HIV comprehensive care, partners, social life, 
psychological impact, internet use and perception discrepancies. Most of these 
concepts are new or bring more detail than the tools in current use. Men having 
sex with men population described specific topics such as stigma and substance 
use. Sexuality difficulties were diverse: problems of libido or erection, sexual 
performance and pleasure, reluctance to have sex, sexual intercourse in spite of 
oneself, fear of transmission or of contamination and difficulty of using condoms. 
The deterioration in the quality of sexual life was reflected in global sexual dis-
satisfaction. cOnclusiOns: Sexual dysfunction in PLVHA and PLVHC is important 
and frequent. Qualitative analysis and description of the concepts have led to the 
creation of the framework of a future specific questionnaire.
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Objectives: To understand the relationship between socio-demographic variables, 
clinical factors, highly active anti-retroviral therapy (HAART) and health related 
quality of life (QoL) in HIV-infected individuals participants in the IANUA mul-
ticenter study. MethOds: Data relating to patients with HIV infection admitted 
to 3 infectious disease units in Genoa (Italy) between 2012 and 2014 are collected 
and analyzed. Univariate and multivariate association of demographic and clinical 
factors with QoL (computed using EQ-5D-3L) are examined. QoL determinants are 
assessed using a tobit model, while a logistic model is implemented in order to 
investigate the relation between specific patients characteristics and the likelihood 
of having higher QoL. Results: Results of the empirical modeling suggest that 
being Italian and having a job are positively associated with QoL, whereas being a 
female, taking other drugs in addition to anti-retroviral drugs and being subsidis-
ied are negatively related to QoL. Among clinical factors, last CD4 cell count level 
cannot be considered as significant predictor of QoL, while higher QoL seem to be 
defined by single tablet regimens. cOnclusiOns: The study investigates the major 
determinants of QoL among HIV patients and the results provide some informative 
tools useful to improve strategies aiming at maximizing QoL. As monitoring of QoL is 
nowadays a priority for clinicians, further work will be based on “dynamic” analysis 
comparing QoL at the initial time and QoL at 6-months follow up.
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Objectives: The objective was to estimate patient preferences for simplified treat-
ment regimens, amongst UK HIV patients currently treated with anti-retroviral 
therapy (ART). MethOds: Data were collected via a prospective web-based survey 
(June to October 2014) comprising a discrete choice experiment. A d-efficient design 
was developed in Ngene comprising 12 hypothetical choices of two drug scenarios 
with five attributes (number of tablets (1 to 4), mealtime dosing, increased risk of 
heart attack or insomnia (yes/no), and monthly cost to the healthcare system (£500, 
£600, £750, £1000)). A steering committee of clinicians, nurses, pharmacists, patient 
group representatives and academics, guided the survey design which was tested by 
UK patients. The response patterns were analysed in STATA v13 using generalised 
multinomial logit models (GMNL), including scale heterogeneity multinomial logit, 
mixed logit and fixed-effect logit models. Willingness to pay (WTP) in GBP was used 
as a metric to quantify the strength of preference for each attribute. Results: 
Results: Responses were analysed for 278 UK patients currently receiving ART. 72.6% 
were men who have sex with men, 14.7% were female. Median age was 44 (range 
21-66) years, time since diagnosis 8 (0-30) years and 5 (0-27) years duration of treat-
ment. Across the models, the attributes were ranked similarly, though the range 
of WTP was more extreme for some models than others. Based on the best fitting 
model (GMNL with correlated random-effects), patients were most willing to pay 
for the avoidance of insomnia (£1083, 95% CI £500-£1664), then one tablet per day 
(£934, CI £461-£1406), avoidance of a heart attack (£589, CI £231-£947) then avoid-
ing mealtime dosing (£516, CI £242-£790). cOnclusiOns: UK HIV patients have 
a strong preference for avoiding treatment related insomnia, followed by a single 
